Vitality Biopharma to Present at LD Micro and BIO Conferences

ID: 1438770
recent pressrelease next pressrelease

(businesspress24) - LOS ANGELES, CA -- (Marketwired) -- 06/01/16 -- Vitality Biopharma, Inc. (OTCQB: STVF), a company dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced that Company CEO Mr. Robert Brooke will be presenting and meeting with investors at the upcoming 2016 LD Micro Invitational and BIO International Conference in June.

Vitality Biopharma to present on Tuesday, June 7th at 7:30AM PST. The conference will be held at the Luxe Sunset Bel Air Hotel in Los Angeles and will feature 195 companies in the small / micro-cap space.

Vitality Biopharma to present on Thursday, June 9th at 11:00AM PST in Theatre 2. The convention will be held at the Moscone Center in San Francisco, June 6-9 and provides an opportunity to network with 2,500 CEOs and 15,000+ attendees from 69 countries.

Stevia First Corp. (OTCQB: STVF) recently received shareholder approval for a name change to Vitality Biopharma, Inc. Submission for a new trading symbol is underway.

Vitality Biopharma is dedicated to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. For more information, visit: . Follow us on , and .

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event). For those interested in attending, please visit for more information.

The BIO International Convention (BIO) attracts over 15,000 biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. This event covers a wide spectrum of life science and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology, and cell therapy. For more information visit: .


More information: http:// http:// http:/

Keywords (optional):

stvf, vitality-biopharma, cannabinoids, neurological, inflammatory, disorders, multiple-sclerosis,

Company information / Profile:

PressRelease by


PressContact / Agency:

published by: Marketwired
print pressrelease  send to a friend  

Date: 06/01/2016 - 07:00
Language: English
News-ID 1438770
Character count: 2756
Firma: Vitality Biopharma, Inc.
Ansprechpartner: Feedback to about Pressrelease-id:


Number of hits: 140


Direct Link to this PressRelease:

We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease

All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 49

Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.